Impact of Systemically Active Neurohumoral Factors on the Erectile Response of the Rat

Journal of Sexual Medicine

Volumn 8, Issue 9, 2011, Pages 2461-2471

  Mackenzie, Lindsay D ^a   Heaton, Jeremy P W ^a   Adams, Michael A ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Cavernous Nerve Electrostimulation; Erectile Dysfunction; Erectile Mechanisms; Mean Arterial Pressure; Sprague Dawley Rat; Vasoactive Factors

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; HEXAMETHONIUM; LOSARTAN; METHOXAMINE; TERBUTALINE; VASOACTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAVA VEIN; CIRCULATION; CONTROLLED STUDY; ELECTROSTIMULATION; INTRACRANIAL PRESSURE; MALE; MEAN ARTERIAL PRESSURE; NERVE STIMULATION; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 80052462987     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02333.x     Document Type: Article

References (46)

1. Mills TM, Stopper VS, Weidmeier VT. Effects of castration and androgen replacement on the hemodynamics of penile erection in the rat. Biol Reprod 1994;51:234-8.
2. Lue TF. Physiology of penile erection and pathophysiology of erectile dysfunction and priapism. Walsh PC, Retik AB, Vaughn ED, eds. Campbell's urology. Toronto: W.B. Saunders; 2002:1157-72.
3. Saenz de Tejada I, Angulo J, Cellek S, Gonzalez-Cadavid N, Heaton J, Pickard R, Simonsen U. Physiology of erectile function. J Sex Med 2004;1:254-65.
4. Billups KL. Sexual dysfunction and cardiovascular disease: Integrative concepts and strategies. Am J Cardiol 2005;96(12B):57M-61M.
5. Inman BA, St. Sauver JL, Jacobson DJ, McGree ME, Nehra A, Lieber MM, Roger VL, Jacobson SJ. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 2009;84:108-13.
6. Jackson G, Montorsi P, Adams MA, Anis T, El-Sakka A, Miner M, Vlachopoulos C, Kim E. Cardiovascular aspects of sexual medicine. J Sex Med 2010;7:1608-26.
7. Chew KK, Finn J, Stuckey B, Gibson N, Sanfilippo F, Bremner A, Thompson P, Hobbs M, Jamrozik K. Erectile dysfunction as a predictor for subsequent atherosclerotic cardiovascular events: Findings from a linked-data study. J Sex Med 2010;7:192-202.
8. Hale TM, Okabe H, Heaton JPW, Adams MA. Antihypertensive drugs induce structural remodeling of the penile vasculature. J Urol 2001;166:739-45.
9. Wingard C, Fulton D, Husain S. Altered penile vascular reactivity and erection in the Zucker obese-diabetic rat. J Sex Med 2007;4:348-62.
10. Okabe H, Hale TM, Kumon H, Heaton JPW, Adams MA. The penis is not protected-In hypertension there are vascular changes in the penis which are similar to those in other vascular beds. Int J Impot Res 1999;11:133-40.
11. Eardley I, Donatucci C, Corbin J, El-Meliegy A, Hatzimouratidis K, McVary K, Munarriz R, Lee SW. Pharmacotherapy for erectile dysfunction. J Sex Med 2010;7:524-40.
12. Gratzke C, Angulo J, Chitaley K, Dai YT, Kim NN, Paick JS, Simonsen U, Uckert S, Wespes E, Andersson KE, Lue TF, Stief CG. Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med 2010;7:445-75.
13. Fogari R, Zoppi A. Effects of antihypertensive therapy on sexual activity in hypertensive men. Curr Hypertens Rep 2002;4:202-10.
14. Bohm M, Baumhakel M, Teo K, Sleight P, Probstfield J, Gao P, Mann JF, Diaz R, Dagenais GR, Jennings GL, Liu L, Jansky P, Yusuf S. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) trials. Circulation 2010;121:1439-46.
15. Hale TM, Shoichet MJ, Bushfield TL, Adams MA. Time course of vascular structural changes during and after short-term antihypertensive treatment. Hypertension 2003;42:171-6.
16. Hale TM, Okabe H, Bushfield TL, Heaton JPW, Adams MA. Recovery of erectile function after brief aggressive antihypertensive therapy. J Urol 2002;168:348-54.
17. Hannan JL, Heaton JP, Adams MA. Recovery of erectile function in aging hypertensive and normotensive rats using exercise and caloric restriction. J Sex Med 2007;4:886-97.
18. Park K, Ahn KY, Kim MK, Lee SE, Kang TW, Ryu SB. Intracavernosal injection of vascular endothelial growth factor improves erectile function in aged rats. Eur Urol 2004;46:403-7.
19. Chitaley K, Webb RC, Dorrance AM, Mills TM. Decreased penile erection in DOCA-salt and stroke prone-spontaneously hypertensive rats. Int J Impot Res 2001;13(5 suppl):S16-20.
20. Seyde WC, Longnecker DE. Anesthetic influences on regional hemodynamics in normal and hemorrhaged rats. Anesthesiology 1984;61:686-98.
21. Haberle DA, Davis JM, Kawabata M, Metz C, Wapler P, Stachl M. Renal and single-nephron function is comparable in thiobutabarbitone- and thiopentone-anaesthetized rats. Pflugers Arch 1993;424:224-30.
22. Tucker BJ, Peterson OW, Ziegler MG, Blantz RC. Analysis of adrenergic effects of the anesthetics Inactin and α-chloralose. Am J Physiol 1982;243:F253-9.
23. Smallegange C, Hale TM, Bushfield TL, Adams MA. Persistent lowering of pressure by transplanting kidneys from adult spontaneously hypertensive rats treated with brief antihypertensive therapy. Hypertension 2004;44:89-94.
24. Fenoy FJ, Milicic I, Smith RD, Wong PC, Timmermans PB, Roman R. Effects of Dup 753 on renal function of normotensive and spontaneously hypertensive rats. Am J Hypertens 1991;4:321S-6S.
25. Hatzichristou DG, Hatzimouratidis K, Tzortzisl V, Apostolidis A, Bekos A, Ioannidis E. Normal hemodynamic parameters do not always predict the presence of a rigid erection: A quantitative assessment of functional erectile impairment. Int J Impot Res 2003;15:99-104.
26. Fandel TM, Bella AJ, Tantiwongese K, Garcia M, Nunes L, Thuroff JW, Tanagho EA, Pohl J, Lue TF. The effect of intracavernosal growth differentiation factor-5 therapy in a rat model of cavernosal nerve injury. BJU Int 2006;98:632-6.
27. Bennet NE, Kim JH, Wolfe DP, Sasaki K, Yoshimura N, Goins WF, Huang S, Nelson JB, DeGroat WC, Glorioso JC, Chancellor MB. Improvement in erectile dysfunction after neurotrophic factor gene therapy in diabetic rats. J Urol 2005;173:1820-4.
28. Behr-Roussel D, Gorny D, Katell M, Compagnie S, Kern P, Sivan V, Bernabe J, Bedigian MP, Alexandre L, Giuliano F. Erectile dysfunction: An early marker for hypertension? A longitudinal study in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2005;288:R276-83.
29. Mullerad M, Donohue JF, Li PS, Scardino PT, Mulhall JP. Functional sequelae of cavernous nerve injury in the rat: Is there model dependency. J Sex Med 2006;3:77-83.
30. Yang CC, Porter MP, Penson DF. Comparison of the International Index of Erectile Function erectile domain scores and nocturnal penile tumescence and rigidity measurements: Does one predict the other? BJU Int 2006;98:105-9.
31. Rehman J, Christ G, Melman A, Fleischmann J. Intracavernous pressure responses to physical and electrical stimulation of the cavernous nerve in rats. Urology 1998;51:640-4.
32. Penson DF, Ng C, Rajfer J, Gonzalez-Cadavid NF. Adrenal control of erectile function and nitric oxide synthase in the rat penis. Endocrinology 1997;138:3925-32.
33. Kifor I, Williams GH, Vickers MA, Sullivan MP, Jodbert P, Dluhy RG. Tissue angiotensin II as a modulator of erectile function. I. Angiotensin peptide content, secretion and effects in the corpus cavernosum. J Urol 1997;157:1920-5.
34. Garcia-Reboll L, Mulhall JP, Goldstein I. Drugs for the treatment of impotence. Drugs Aging 1997;11:140-51.
35. Jin L, Lagoda G, Leite R, Webb RC, Burnett AL. NADPH oxidase activation: A mechanism of hypertension-associated erectile dysfunction. J Sex Med 2008;5:544-51.
36. Becker AJ, Uckert S, Stief CG, Scheller F, Knapp WH, Hartmann U, Jonas U. Plasma levels of angiotensin II during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction. J Urol 2001;58:805-10.
37. Hannan JL, Smallegange C, Hale TM, Heaton JPW, Adams MAA. Impact of antihypertensive treatments on erectile responses in aging spontaneously hypertensive rats. J Hypertens 2006;24:159-68.
38. Jin L. Angiotensin II signaling and its implication in erectile dysfunction. J Sex Med 2009;6:302-10.
39. Park K, Shin JW, Oh JK, Ryu KS, Kim SW, Paick J. Restoration of erectile capacity in normotensive aged rats by modulation of angiotensin receptor type 1. J Androl 2005;26:123-8.
40. Llisterri JL, Lozano Vidal JV, Aznar Vincente J, Argaya Roca M, Pol Bravo C, Sanchez Zamorano MA, Ferrario CM. Sexual dysfunction in hypertensive patients treated with losartan. Am J Med Sci 2001;321:336-41.
41. Noboru Toda T, Ayajiki K, Okamura T. Nitric oxide and penile erectile function. Pharmacol Ther 2005;106:233-66.
42. Ohebshalom M, Mulhall JP. Transdermal and topical pharmacotherapy for male sexual dysfunction. Expert Opin Drug Deliv 2005;2:115-20.
43. Domer PC, Wessler G, Brown RL, Charles HC. Involvement of the sympathetic nervous system in the urinary bladder internal sphincter and in penile erection in the anesthetized cat. Invest Urol 1978;15:404-7.
44. Tong YC, Broderick G, Hypolite J, Levin RM. Correlations of purinergic, cholinergic and adrenergic functions in rabbit corporal cavernosal tissue. Pharmacology 1992;45:241-9.
45. Simonsen U, Garcia-Sacristan A, Prieto D. Penile arteries and erection. J Vasc Res 2002;39:283-303.
46. Shantha TR, Finnerty DP, Rodriquez AP. Treatment of persistent penile erection and priapism using terbutaline. J Urol 1989;141:1427-9.